| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |